NCT01160211
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Nowotwór
rak piersi
Chorzy
przerzutowy
Faza badania
III
Sponsor badania
GSK
Termin
-
Linki
Dane kontaktowe
Konin; Lubin; Otwock; Warszawa; Wieliszew; Wrocław